Lopicast - A Drug to Fight Coronavirus

▴ Lopicast - A Drug to Fight Coronavirus
Aprazer Healthcare (p) Ltd.is providng Lopicast - a lifesaving drug for coronavirus at affordable prices. Lopicast is having composition of Ritonavir 50 mg & Lopinavir 200 mg which are recommended to use in coronavirus cases

The endemic of coronavirus started from Wuhan city of China and is knocking the doors of different countries of the world. The deadly symptoms of Coronavirus have put many lives at risk in various regions of the world with maximum effect in Asia especially in China. Continuous attempts are been made to find cure for this virus however considering the growing number of cases doctors have decided to look for some unconventional remedies.

Lopinavir Ritonavir A drug developed to cure HIV infections is used in the treatment of Coronavirus cases. Two antiretroviral components lopinavir and ritonavir are protease inhibitors designed to block HIV viral replication. One hypothesis holds that the drugs could do the same with 2019-nCoV (Coronavirus) which is believed to have originated from the Chinese city of Wuhan.

LOPIKASTis a Generic version of Kaletra now recommended as a treatment for pneumonia caused by the new coronavirus known as 2019-nCoV China National Health Commission says in its updated clinical guidance. Wang Guangfa the leader of Peking University First Hospital pulmonary and critical care medicine department contracted the virus as a member of a national expert team dispatched to Wuhan. Lopinavir Ritonavir tabletskilled his disease Wang told state-run China News Service in areport(Chinese) recently.

In India Aprazer Healthcare Private Limited is a pharmaceutical company based at Delhi which is continuously evolving by providing lifesaving drugs at affordable prices. Aprazer Healthcare Private Limited markets LOPIKAST having composition of Ritonavir 50 mg and Lopinavir 200 mg. As this drug is recommended to use in Coronavirus cases the company has started exporting the product to China and other flu-prone regions at economical prices. The company offers reduced prices of this life-saving drug so that it is easily accessible. Announcing the measures taken by Aprazer Healthcare Pvt. Ltd. CEO of the Company Aprazer said At Aprazer our endeavour is to contribute by supplying the LOPIKAST tablets at the all-time low prices.

He further added that This drug at cost-effective prices will prove to be a stronger response to the prevailing crisis. As it a global emergency we have to face it together.Further he states that If a person is suffering from the expected symptoms of Coronavirus must visit doctor immediately. Lopikast shouldn;t be taken without recommendation and prescription of Physician. According to the doctors treating infected patients of Coronavirus the medicine is not a complete cure for the ailment. However after taking the medicine in combination with flu drug and HIV drug to an infected person the symptoms are expected to improve considerably.

Aprazer Healthcare Pvt. Ltd. has already begun to supply LOPIKAST tablets in the hospitals and cure centres across China. Coronavirus outbreak in China is screaming for assistance from all over the world. The sensitive approach of Aprazers is what other companies should replicate as rightly quoted by Mr. Gandhi. Sometimes profit is not a consideration.

Tags : #Coronavirus #Aprazerhealthcare #Lopicast #Healthcare

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024